While peripheral insulin resistance is common during obesity and aging in mice and humans, its progression to T2D is largely due to insulin secretory dysfunction and significant apoptosis of functional β-cells [5, 34–37], leading to an inability to compensate for insulin resistance. This evidence concerns the gene INS and Insulin resistance.